![David Barrett](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Barrett
Corporate Officer/Principal chez Flame Biosciences LLC
Postes actifs de David Barrett
Sociétés | Poste | Début | Fin |
---|---|---|---|
Flame Biosciences LLC
![]() Flame Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Flame Biosciences, Inc. operates as a biotechnology company. The firm offers research, development and commercialization of transformative therapies for cancer and other inflammatory conditions. The company was founded by Charles J. Fisher Jr., Patrick J. Scannon and Bob Stein and is headquartered in New York, NY. | Corporate Officer/Principal | 01/04/2019 | - |
Historique de carrière de David Barrett
Anciens postes connus de David Barrett
Sociétés | Poste | Début | Fin |
---|---|---|---|
ASSEMBLY BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 17/06/2015 | 08/03/2018 |
Directeur des opérations | 17/06/2015 | 08/03/2018 | |
Directeur Financier/CFO | 17/06/2015 | 08/03/2018 | |
Secrétaire Général | 01/07/2010 | - | |
WOODBROOK GROUP HOLDINGS INC. | Directeur Financier/CFO | 06/04/2006 | 21/07/2009 |
Overture Financial Services LLC
![]() Overture Financial Services LLC Investment ManagersFinance Overture Financial Services LLC specializes in institutional consulting services, infrastructure design, systems implementation and project management for sovereign wealth funds, central banks, social security systems, and financial institutions. The company is headquartered in New York, NY. | Directeur Financier/CFO | 01/01/2005 | 01/04/2006 |
Overture Asset Managers LLC
![]() Overture Asset Managers LLC Investment ManagersFinance Overture Asset Managers LLC acquires boutique money managers and provides investment management services. The private company is based in New York, NY. | Directeur Financier/CFO | 01/09/2003 | 01/01/2005 |
Deloitte & Touche LLP
![]() Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/09/2003 | 01/09/2003 |
FORTRESS BIOTECH, INC. | Directeur/Membre du Conseil | 22/09/2011 | - |
Independent Dir/Board Member | 01/05/2011 | - | |
Ventrus Biosciences, Inc.
![]() Ventrus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ventrus Biosciences, Inc. is a development stage specialty pharmaceutical company engages in development of late-stage prescription drugs for gastrointestinal disorders, specifically hemorrhoidal disease, anal fissures, and fecal incontinence. Its major pharmaceutical progress made in the gastrointestinal therapeutic areas of gastroesophageal reflux, peptic ulcer disease, and inflammatory bowel disease. Ventrus Biosciences products includes VEN 307 (topical diltiazem), is intended to treat pain associated with anal fissures and VEN 308 (topical phenylephrine), is intended to treat fecal incontinence. The company was founded on October 10, 2005 and is headquartered in New York, NY. | Directeur Financier/CFO | 26/07/2010 | - |
Investor Relations Contact | 01/07/2010 | - | |
Public Communications Contact | 01/07/2010 | - |
Formation de David Barrett
University of Florida | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 10 |
Opérationnelle
Director of Finance/CFO | 5 |
Corporate Officer/Principal | 2 |
Investor Relations Contact | 1 |
Sectorielle
Finance | 4 |
Health Technology | 4 |
Commercial Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
WOODBROOK GROUP HOLDINGS INC. | Finance |
FORTRESS BIOTECH, INC. | Health Technology |
ASSEMBLY BIOSCIENCES, INC. | Health Technology |
Entreprise privées | 5 |
---|---|
Overture Financial Services LLC
![]() Overture Financial Services LLC Investment ManagersFinance Overture Financial Services LLC specializes in institutional consulting services, infrastructure design, systems implementation and project management for sovereign wealth funds, central banks, social security systems, and financial institutions. The company is headquartered in New York, NY. | Finance |
Overture Asset Managers LLC
![]() Overture Asset Managers LLC Investment ManagersFinance Overture Asset Managers LLC acquires boutique money managers and provides investment management services. The private company is based in New York, NY. | Finance |
Ventrus Biosciences, Inc.
![]() Ventrus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ventrus Biosciences, Inc. is a development stage specialty pharmaceutical company engages in development of late-stage prescription drugs for gastrointestinal disorders, specifically hemorrhoidal disease, anal fissures, and fecal incontinence. Its major pharmaceutical progress made in the gastrointestinal therapeutic areas of gastroesophageal reflux, peptic ulcer disease, and inflammatory bowel disease. Ventrus Biosciences products includes VEN 307 (topical diltiazem), is intended to treat pain associated with anal fissures and VEN 308 (topical phenylephrine), is intended to treat fecal incontinence. The company was founded on October 10, 2005 and is headquartered in New York, NY. | Health Technology |
Deloitte & Touche LLP
![]() Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
Flame Biosciences LLC
![]() Flame Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Flame Biosciences, Inc. operates as a biotechnology company. The firm offers research, development and commercialization of transformative therapies for cancer and other inflammatory conditions. The company was founded by Charles J. Fisher Jr., Patrick J. Scannon and Bob Stein and is headquartered in New York, NY. | Commercial Services |
- Bourse
- Insiders
- David Barrett
- Expérience